Intellirod Spine raised >US $1.0MM in additional equity financing from new and existing investors, including Queen City Angels and JumpStart. Funds will be used to reach key milestones toward commercialization of sensor technologies and lumbar fusion implants.
Intellirod Spine is pursuing both a de novo 510(k) and CE Mark approval for LOADPRO™, an intra-operative sensor for monitoring rod strain during kyphotic correction.
Further, pre-clinical testing is complete in support of an FDA application for ACCUVISTA™, an implantable version of LOADPRO.
Intellirod Spine raised >US $1.0MM in additional equity financing from new and existing investors, including Queen City Angels and JumpStart. Funds will be used to reach key milestones toward commercialization of sensor technologies and lumbar fusion implants.
Intellirod Spine is pursuing both a de novo 510(k) and CE Mark approval for...
Intellirod Spine raised >US $1.0MM in additional equity financing from new and existing investors, including Queen City Angels and JumpStart. Funds will be used to reach key milestones toward commercialization of sensor technologies and lumbar fusion implants.
Intellirod Spine is pursuing both a de novo 510(k) and CE Mark approval for LOADPRO™, an intra-operative sensor for monitoring rod strain during kyphotic correction.
Further, pre-clinical testing is complete in support of an FDA application for ACCUVISTA™, an implantable version of LOADPRO.
Copy to clipboard 
